News about Biotechnology, Pharmaceutical and Healthcare

12:38 EST 10th February 2016 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 14,000+

Wednesday 10th February 2016

RPS welcomes new toolkit highlighting risks of valproate use during pregnancy

The Royal Pharmaceutical Society (RPS) welcomes the launch of a MHRA toolkit outlining the risks associated with female patients using valproate during pregnancy. 

Q&A: The story on the Zika virus and microcephaly so far

David Heymann talks about the Zika virus and microcephaly, the latest global public health emergency, and what is being done to tackle it.

LifeStyles, Skyn condoms get millennial-appealing makeover

Michael JohnsenThis redesign was initiated to build excitement surrounding safe sex, highlight pleasure enhancing product attributes, and appeal to the brand's key millennial demographic with a bold new look. read more

Resources launched to help female patients understand risks of valproate treatment

A credit card-sized patient information card that pharmacists can give to female patients to warn them about the risks of taking valproate while pregnant has been produced by the Medicines and Healthcare products Regulatory Agency.

Why the New General Market still matters

Drug Store News and Mack Elevation Forum are partnering on the Second Annual New General Market Leadership Forum, which will consist of a group of special brands that are committed to today’s diverse consumer.  read more

What’s Next: Niche multicultural brands make inroads

Lonni DelaneIn the latest installment of What’s Next, Lonni Delane takes a look at Cosmoprof North America’s efforts to appeal to multicultural consumers.  read more

CVS Health's Accordant receives NCQA Case Management Accreditation

Michael JohnsenAs part of the Case Management program, Accordant manages care transitions and identifies and prevents potential problems to help members avoid emergency room visits and extended hospital stays. read more

MSD’s Zepatier approval could spell end of Gilead’s Hep C dominance, says analyst

The introduction of MSDs’ recently FDA-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market long-dominated by Gilead, according to an analyst with research and consulting firm GlobalData. Daian Cheng, GlobalData’s infectious diseases analyst, says the combination of Zepatier’s strong clinical profile and competitive pricing- revealed by the ...

A generous $1.6 million donated as part of Rite Aid Foundation's Big Heart Gives Challenge

Michael JohnsenKen Martindale, in his capacity as president of The Rite Aid Foundation, kicked off the month-long celebration by presenting a $12,500 donation to Nativity School of Harrisburg, a faith-based preparatory middle school for inner city boys.    read more

Monoclonal antibody shows promise for chronic sinusitis

Study shows dupilumab therapy improves smell, sinus volume and inspiratory flow in patients with polyps.

NICE recommends nintedanib

The National Insitute for Health and Care Excellence (NICE) has recommended nintedanib as an option for treating idiopathic pulmonary fibrosis if the person has between 50% and 80% of their predicted forced vital capacity (FVC); the company provides nintedanib with the discount agreed in the patient access scheme; and treatment is stopped if disease progresses (a confirmed decline in percent pre...

RPS launches new tool kit to help members become social media savvy

The Royal Pharmaceutical Society has released a new toolkit of advice and tips to help its members become expert in using social media to aid their professional development and promote the pharmacy profession.

Carter review calls for more clinical pharmacists to be deployed by NHS trusts

NHS trusts should deploy more clinical pharmacists, including pharmacist prescribers, and use them to drive value from the £6.7bn that NHS hospitals spends on medicines every year, Lord Carter has advised in his final review of English NHS acute hospitals.

National Pharmacy Board Elections 2016

Closure of electoral roll and deadline for updating voting preferences

NICE publishes new myeloma guidance

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. The best way to diagnose, treat and monitor multiple myeloma - a type of blood cancer - has been set out in guidance published today by the National Institute for Health and Care Excellence (NICE).  read more

FDA votes 21-3 in favour of Remicade biosimilar; Pfizer preps for 2016 launch

A US FDA advisory committee has voted overwhelmingly in favour of licensing Celltrion and Pfizer’s version of J&J’s Remicade, paving the way for the first US monoclonal antibody biosimilar.

Novartis says CDF proposals place “unreasonable” risk on pharma

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is operated, as the consultation period on the proposals come to an end, saying a number of the suggestions are “not workable”. The Swiss-based company, one of the largest pharma companies in the world, says changes due to come in from April 2016 could result in patients being “denied acce...

Eluxadoline effective for a third of IBS patients

Patients taking 100mg dose of eluxadoline saw improvements in IBS symptoms during the first 26 weeks of treatment.

Heptares announces positive early-stage dementia trial results

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for patients with cognitive impairment due to dementia and schizophrenia. In the Phase 1b study, 28 healthy elderly subjects were given different doses of HTL9936, to test the effect of drug on measures of brain activity while simultaneously monitoring side effects. Result...

FDA advisory committee recommends approval of Remicade biosimilar

An FDA advisory panel yesterday voted overwhelmingly in favour of approving CT-P13- Celltrion’s biosimilar version of Johnson&Johnson’s blockbuster arthritis drug Remicade (infliximab). The agency’s arthritis advisory panel voted 21-3 in favour of the South Korean company’s copycat version, which it co-markets with Pfizer, having revealed in a briefing document published yesterday that...

Tuesday 9th February 2016

Advising moms not to bed share with infants does not discourage breastfeeding

NIH-funded study lends support to SIDS reduction advice.

SKIPPY brings a bit more fun into the snacking aisle

Gina AcostaThe makers of the popular SKIPPY brand of peanut butter have taken the taste of SKIPPY and put it into bite-size snacks. read more

Finn Futures survey looks at gaps in patient knowledge, healthcare system

Among the survey’s findings is the fact that when it comes to prescriptions, many respondents trust their pharmacist’s advice.  read more

Colgate introduces Advanced Health Daily Repair toothpaste

Gina AcostaColgate-Palmolive Canada is introducing an product to the dental care aisle that encourages consumers to be proactive about their oral health. read more

Big brands 'band' together against stretch marks

Gina AcostaTwo leading post-partum brands are joining together to offer women a "double dose" of stretch mark treatment and care. read more

Quick Search